Results
1 -
9 of
9
(Click
here to explore results)
Biomedical Imaging: The Chemistry of Labels, Probes and Contrast Agents, Chapter 3 Recent Developments in PET and SPECT Radioligands for CNS Imaging . David Alagille, Ronald M. Baldwin, Gilles D. Tamagnan
, 2012
, Pages 49-143
Biophysical Techniques in Drug Discovery, Chapter 11 Molecular Imaging . Eugen Kubala, Marion I. Menzel, Benedikt Feuerecker, Steffen J. Glaser, Markus Schwaiger
, 2018
, Pages 277-306
Nanotechnology for Diabetes Management, Chapter 4 Amyloidosis Inhibition and Detection of Human Islet Amyloid Polypeptide with Nanomaterials . Aleksandr Kakinen, Nicholas Andrikopoulos
, 2023
, Pages 113-127
Perfluoroalkyl Substances: Synthesis, Applications, Challenges and Regulations, CHAPTER 9 Fluorine in Medicine . H. Yamaguchi
, 2022
, Pages 440-458
Neurodegeneration: Metallostasis and Proteostasis, Chapter 8 Biological Metals: Metallostasis and Alzheimer's Disease . A. Rembach, J. A. Duce, L. A. O’Sullivan, R. E. Tanzi, A. I. Bush
, 2011
, Pages 152-173
Emerging Drugs and Targets for Multiple Sclerosis, CHAPTER 9 Emerging Drugs and Targets for Remyelination in Multiple Sclerosis . Laura J. Wagstaff, Anna Williams
, 2019
, Pages 197-221
Advances in Biological Solid-State NMR: Proteins and Membrane-Active Peptides, CHAPTER 27 NMR Studies of Small Molecules Interacting with Amyloidogenic Proteins . Elke Prade, Juan-Miguel Lopez del Amo, Bernd Reif
, 2014
, Pages 533-555
Alzheimer's Disease: Recent Findings in Pathophysiology, Diagnostic and Therapeutic Modalities, Chapter 14 Circulating Biomarkers for the Diagnosis of Alzheimer's Disease . Siranjeevi Nagaraj, Madhu Ramesh, Thimmaiah Govindaraju
, 2022
, Pages 415-441
Emerging Drugs and Targets for Alzheimer's Disease: Volume 1: Beta-Amyloid, Tau Protein and Glucose Metabolism, Chapter 14 Ketone Bodies as a Therapeutic for Alzheimer's Disease . Samuel T. Henderson
, 2010
, Volume 1
, Pages 275-306